Skip to content

Myofascial Release With and Without Autogenic Inhibition Muscle Energy Technique in Non-specific Chronic Neck Pain

Effects of Myofascial Release With and Without Autogenic Inhibition Muscle Energy Technique in Patients With Non-specific Chronic Neck Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07331571
Enrollment
44
Registered
2026-01-12
Start date
2025-01-13
Completion date
2025-10-31
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Specific Chronic Neck Pain

Keywords

Neck Ache, Myofascial Release Therapy, Autogenic Inhibition Technique, Muscle Energy Technique, Chronic Neck Pain

Brief summary

The study was conducted to determine the effects of myofascial release therapy with and without autogenic inhibition muscle energy technique in patients with non-specific chronic neck pain.

Interventions

AI MET was applied for upper trapezius 5 times for each side, similarly for levator scapulae it was applied 5 times for each side. AI MET was applied for posterior, middle and anterior fibres of scalene muscle. For sternocleidomastoid muscle it was applied for at least twice for each side. 8 sessions were conducted for 6 weeks, with 3 sessions scheduled every week.

OTHERMyofasical Release Therapy

MFR for upper trapezius and levator scapulae was carried out 5 times for each side. A total of 18 sessions were conducted for 6 weeks, with 3 sessions scheduled every week.

Electric hot pack for 10 minutes for 10 minutes, TENS with frequency of 120Hz at low intensity having pulse duration of 50-200μs for 10 minutes & Grade I and II Maitland posteroanterior central glide with 3 sets of 30 oscillations, for alleviation of pain at the target vertebral segment.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Neck pain for at least 3 months * Pain intensity on NPRS between 4 to 7 * Limited neck range of motion * Use of computer for at least 2 hours daily * Negative Sharp-Purser and alar ligaments test (to rule out atlantoaxial instability, integrity of transverse and alar ligaments)

Exclusion criteria

* History of trauma * Cervical spine fracture * Open neck surgery * Cervical radiculopathy * Paresthesia * Cervical myelopathy * Rheumatoid Arthritis * Ankylosing Spondylitis * Multiple Sclerosis * Fibromyalgia * Hemorrhage tendency and/or anticoagulation treatment * Whiplash Injury

Design outcomes

Primary

MeasureTime frameDescription
Numeric Pain Rating ScaleFrom enrollment to the end of treatment at 6 weeksNumeric Pain Rating Scale is utilized to evaluate pain. It consists of 11 points, having an overall score ranging from 0 and 10, where: 0 represents no pain, 1 - 3 represents mild pain, 4 - 6 represents moderate pain and 7 - 10 represents the most severe pain.
Neck Disability IndexFrom enrollment to the end of treatment at 6 weeksNeck Disability Index is a questionnaire that has 10-questions for determining cervical pain and functional disability linked with the activities of daily living. It consists of questions on pain intensity, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. Scores in each item is described in 6 stages, from 0 to 5 points. The total of 0-4 points indicate no disability, 5-14 points indicate mild disability, 15-24 points indicate moderate disability, 25-34 points indicate severe disability and 35-50 points indicate complete disability

Secondary

MeasureTime frameDescription
ROM Cervical Spine (Lateral Flexion) Left SideFrom enrollment to the end of treatment at 6 weeksChanges in cervical spine lateral flexion on left side ROM at baseline and 6th week of intervention was measured using goniometer.
ROM Cervical Spine (Lateral Flexion) Right SideFrom enrollment to the end of treatment at 6 weeksChanges in cervical spine lateral flexion on right side ROM at baseline and 6th week of intervention was measured using goniometer.
ROM Cervical Spine (Flexion)From enrollment to the end of treatment at 6 weeksChanges in cervical spine flexion ROM at baseline and 6th week of intervention was measured using goniometer.
ROM Cervical Spine (Rotation) RightFrom enrollment to the end of treatment at 6 weeksChanges in cervical spine rotation on right side ROM at baseline and 6th week of intervention was measured using goniometer.
ROM Cervical Spine (Rotation) Left SideFrom enrollment to the end of treatment at 6 weeksChanges in cervical spine rotation on left side ROM at baseline and 6th week of intervention was measured using goniometer.
ROM Cervical Spine (Extension)From enrollment to the end of treatment at 6 weeksChanges in cervical spine extension ROM at baseline and 6th week of intervention was measured using goniometer.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026